Tag: Cancer: Prostate

Among men analyzed with DRE as solitary screening test for prostate cancer, suspicious findings did not increase prostate cancer detection

Considerable variation observed in active surveillance use, from 4.0 to 78.0 percent at practice level and from 0 to 100 percent at practitioner level

Multiancestry polygenic risk score can stratify prostate cancer risk and differentiate risk for aggressive disease

Findings seen for men treated with enzalutamide for nonmetastatic castration-resistant prostate cancer

Prevalence of colorectal cancer screening remained unchanged with increase in stool testing offsetting decrease in colonoscopy

Longer duration of imaging-based progression-free survival seen in intent-to-treat population and those with BRCA mutation

Improvement seen in median imaging-based progression-free survival, regardless of homologous recombination repair status

Men in highest quintile of plant-based dietary index had significantly lower risk for prostate cancer progression and recurrence

15-item measure deemed by key stakeholders to be relevant and useful in context of RNT for prostate cancer

Greater number of negative posttreatment biopsies seen among men with higher baseline genomic risk score